tradinglifeline

FSL WEEKLY ROUNDING BOTTOM FORMATION

Long
NSE:FSL   FIRSTSOURCE SOLUTI
Scrip had made it's all-time high in July 2021. Now giving bullish reversal signals.

Technical Positives
=================
• 50 SMA crossed above 200 SMA which is known as Golden Cross over.
• Price has shown trend reversal and broke weekly bearish super tren'd and after consolidation, it started its upward journey
• It is making rounding bottom formation.
• It gave reverse head and shoulder break out last week which also indicates bullish view
• EMAs expanding after contraction

Probable Targets
===============
1st 183, 29% above the CMP
2nd 217 to 229, more than 57% above the CMP
3rd 360, 154% above the CMP

I kindly request your valuable feedback on the accuracy and validity of my learning and research. Furthermore, I would greatly appreciate any suggestions on areas where I can enhance my skills and knowledge.

DISCLAIMER:
===========
The perspective I am providing may possess inherent bias. My family members and me may and may not have financial investment in aforementioned scrip. Consequently, it is within my prerogative to engage in the purchase or sale of said scrip at my discretion, contingent upon prevailing market conditions and the occurrence of specific events.
I am not a registered financial advisor and the information provided by me should not be considered as financial advice. It is highly recommended that you consult with your financial advisor and do your due diligence before making any investment decisions.
Investing in the stock market is subject to market conditions and any unforeseen events. Also involves risk and can result in both profit and loss. You should be aware of the risks involved in investing in the stock market before making any investment decisions.
Please note that any investment decision you make based on the information provided by me is at your own risk, I will not be held responsible for any of your losses or damages, financial or otherwise, resulting from your investment decisions.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.